SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?


To: Ken W who wrote (27190)11/23/2001 10:58:49 AM
From: JoeinIowa  Read Replies (1) | Respond to of 29382
 
Ken,

Your not going to start those fish references again? They seemed to go a little overboard last time. LOL.

Not much going today. ASTT had a huge block go by this morning. THDO does not want to come down.

Joe



To: Ken W who wrote (27190)11/23/2001 12:57:57 PM
From: Sergio H  Read Replies (3) | Respond to of 29382
 
Hi Ken. There's not much volume in today's market. Hopefully everyone's out shopping.

I think EDSN is good for more on todays news. Earnings are out of the way and the hedging pending resolution of the Philly story should now unwind.

Agree on KARE. I couldn't find any ace in the hole for them to pull out. I noticed Joe didn't care for this stock and Bobb Rudd on the Value Investing thread didn't find anything there either. Value Investing thread is a recommended read.

In spite the relative calm market, there's some good action on the biotechs. I'm still long IBB, in play due to the index rotation coming up. There's also a good play in smallpox vaccines. The Dept of Health & Human Services is expected to make a decision Sunday or Monday on which companies may produce the smallpox vaccine. The 3 co's bidding: GSK , MRK , BAX

I'm thinking that all three will win. Looking at buying some calls...probably on BAX.

Also, the oil stocks should get a rebound soon. The Russians will agree to cut production at some point. They're not in biz to give away their product.

Sergio